Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis

J Neurosci. 2004 Mar 17;24(11):2837-45. doi: 10.1523/JNEUROSCI.4789-03.2004.

Abstract

The cytokine interleukin-1beta (IL-1beta) is critical to the formation of an astrocytic scar after CNS injury, but the mechanisms by which it induces a reactive phenotype remain unresolved. Here, we show that IL-1beta regulates the phenotype of astrocytes via deactivation of the Rho GTPase-Rho kinase (ROCK) pathway, which governs cellular morphology and migration via effects on F-actin and its interactions with focal adhesions, nonmuscle myosin, and microvillar adapter proteins of the ezrin-radixin-moesin (ERM) family. We found that IL-1beta induced cortical reorganization of F-actin and dephosphorylation of focal adhesion kinase, myosin light chain 2, and myosin phosphatase targeting subunit 1 in primary human astrocytes, and that all of these effects were mimicked by Rho-ROCK pathway blockade. We also found that IL-1beta conversely potentiated ERM phosphorylation, and that this effect was mediated via a Rho-ROCK-independent mechanism. Next, we used a rhotekin pulldown assay to confirm directly that IL-1beta deactivates Rho, and further demonstrated that a constitutively active Rho construct rescued astrocytes from developing an IL-1beta-induced reactive phenotype. These data implicate cytokine regulation of the Rho-ROCK pathway in the generation of a reactive astrogliosis, and we suggest that interventions targeted at this level may facilitate manipulation of the glial scar in inflammatory disorders of the human CNS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Astrocytes / drug effects*
  • Astrocytes / metabolism*
  • Astrocytes / ultrastructure
  • Cell Movement / drug effects
  • Cells, Cultured
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / metabolism
  • Enzyme Inhibitors / pharmacology
  • Fetus
  • Focal Adhesions / drug effects
  • Focal Adhesions / ultrastructure
  • Humans
  • Interleukin-1 / pharmacology*
  • Intracellular Signaling Peptides and Proteins
  • Phenotype
  • Phosphorylation / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Time Factors
  • Transcription Factors / drug effects
  • Transcription Factors / metabolism
  • rho GTP-Binding Proteins / antagonists & inhibitors
  • rho GTP-Binding Proteins / metabolism*
  • rho-Associated Kinases

Substances

  • DNA-Binding Proteins
  • ETV5 protein, human
  • Enzyme Inhibitors
  • Interleukin-1
  • Intracellular Signaling Peptides and Proteins
  • Transcription Factors
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases
  • rho GTP-Binding Proteins